Queens Cancer Center is a clinical research site located in Rego Park, New York, United States 11374.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Queens Cancer Center has participated in 15 clinical trials with 14 currently active.
Therapeutic areas: Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8, Ovarian Carcinoma.
Sponsors: Alliance for Clinical Trials in Oncology, NRG Oncology, ECOG-ACRIN Cancer Research Group.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Queens Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Queens Cancer Center has 15 clinical trials on record, with 14 currently active. Their work covers Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8, Ovarian Carcinoma.
Yes — Queens Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.